R. Snyder - Recombinant AAV Vectors: persistence in vivo and clinical product release

Regenerative Medicine and Gene Therapy

English - October 21, 2010 10:00 - 1 hour - 523 MB Video
Science Health & Fitness Medicine trieste gene therapy gene therapy icgeb genetica Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: T. Cathomen - Zinc positive: designer nucleases in gene therapy

Next Episode: M. Capogrossi - HMGB1 and left ventricular remodeling after infarction

Richard Snyder, Biotherapeutic Programs, Office of Research, Department of Molecular Genetics and Microbiology, University of Florida, USA speaks on "Recombinant AAV Vectors: persistence in vivo and clinical product release". This seminar has been recorded by ICGEB Trieste